Meeting on the Pathogenesis of Clostridia

产品说明： 请求提供资金，以支助第七次梭菌分子生物学和发病机制国际会议。该会议自1995年以来每2-3年举行一次，已成为该领域的首要会议。Clostridium spp.人类和动物疾病的发病率和严重程度一直在增加。幸运的是，对这些物种的研究的广度和深度也在不断增加。因此，召开这次会议的必要性是紧迫的，其时机也是非常恰当的。组织委员会的成员反映了会议的地位;成员是该领域的领导者，涵盖从毒素生物化学，细胞生物学和分子流行病学到基因调控和遗传操作的专业。会议将于2011年10月25日至29日在爱荷华州州立大学校园举行。预计与会者人数约为175人，来自美国（约占与会者的一半）以及欧洲、亚洲和大洋洲的许多国家。对于11个科学会议中的每一个，在亚专业前沿工作的发言者都同意介绍他们的最新工作。此外，从提交摘要的人中选出3-4名年轻科学家将被邀请在每次会议上发言。会议的目的是最大限度地扩大与会者之间的互动，同时向有需要的人提供家庭护理和残疾人无障碍环境。 将积极征集团体。 公共卫生相关性： 梭菌属是世界上对人类和动物最具破坏性的病原体之一。在了解梭菌介导的疾病的生物化学和流行病学方面的最新进展以及病原菌遗传操作方面的最新飞跃大大增加了我们的知识，同时开辟了新的研究途径。对最近结果的深入讨论预计将导致合作，这将导致设计和测试新疗法的新方法。

DESCRIPTION: Funds are requested to support the Seventh International Meeting on the Molecular Biology and Pathogenesis of the Clostridia. This meeting, which has been held every 2-3 years since 1995, has become the premier meeting in its field. The involvement of Clostridium spp. in human and animal disease has been increasing in incidence and severity. Luckily, the breadth and depth of research on these species has also been increasing. Thus, the need for the meeting is urgent and its timing is highly appropriate. The membership of the organizing committee reflects the stature of the meeting; the members are leaders in the field and cover specialties ranging from toxin biochemistry, cell biology and molecular epidemiology to gene regulation and genetic manipulation. The meeting will be held from October 25-29, 2011 on the campus of Iowa State University. Attendees are expected to number about 175 and to come from the US (about half the attendees) and from many countries in Europe, Asia, and Oceania. For each of the 11 scientific sessions, speakers working at the cutting edge of the subspecialty have agreed to present their latest work. In addition, 3-4 junior scientists chosen from among the abstract submitters will be invited to speak at each session. The meeting has been designed to maximize interactions among the participants, while providing family care and handicapped accessibility to those who need it. Participation by scientists from traditionally underrepresented groups will be actively solicited. PUBLIC HEALTH RELEVANCE: Clostridium species are among the world's most devastating pathogens for humans and animals. Recent advances in understanding the biochemistry and epidemiology of Clostridium-mediated disease and recent leaps forward in genetic manipulation of the pathogenic bacteria have greatly increased our knowledge while opening up major new avenues for research. In-depth discussion of recent results is expected to lead to collaborations that will lead to new ways of designing and testing novel therapeutics.